Page last updated: 2024-10-18

dihydroxyphenylalanine and Myotonic Dystrophy

dihydroxyphenylalanine has been researched along with Myotonic Dystrophy in 1 studies

Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.

Myotonic Dystrophy: Neuromuscular disorder characterized by PROGRESSIVE MUSCULAR ATROPHY; MYOTONIA, and various multisystem atrophies. Mild INTELLECTUAL DISABILITY may also occur. Abnormal TRINUCLEOTIDE REPEAT EXPANSION in the 3' UNTRANSLATED REGIONS of DMPK PROTEIN gene is associated with Myotonic Dystrophy 1. DNA REPEAT EXPANSION of zinc finger protein-9 gene intron is associated with Myotonic Dystrophy 2.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Atarashi, J1
Terashi, A1

Reviews

1 review available for dihydroxyphenylalanine and Myotonic Dystrophy

ArticleYear
[Recent progress in neurology].
    Naika. Internal medicine, 1971, Volume: 27, Issue:1

    Topics: Abdomen; Brain Death; Cerebrovascular Disorders; Demyelinating Diseases; Diffuse Cerebral Sclerosis

1971